Hepatitis C Management in Unique and Key Populations

Description

Experts examine and discuss the latest information regarding the management of special populations with chronic HCV infection. The unique and key populations addressed in the session include men who have sex with men, transgender individuals, persons in carceral facilities, pregnant individuals, children, and people who inject drugs.

Journey Maps

Presentations

2:00 PM - 2:20 PM
Nov 08 2025
San Diego, CA

Invisible Frontlines: Combating Hepatitis C in Men Who Have Sex With Men and Transgender Communities

Daniel Fierer, MD, Presenter
Hepatitis
2:20 PM - 2:40 PM
Nov 08 2025
San Diego, CA

Generational Health: Eliminating Hepatitis C Among Pregnant Individuals and Children

Catherine Chappell, Presenter
Hepatitis
2:40 PM - 3:00 PM
Nov 08 2025
San Diego, CA

From Harm to Healing: Eliminating Hepatitis C Among People Who Inject Drugs

Natasha K. Martin, PhD, Presenter
Hepatitis
3:00 PM - 3:20 PM
Nov 08 2025
San Diego, CA

Behind Bars, Not Beyond Reach: Tackling Hepatitis C in Correctional Settings

Matthew J Akiyama, MD, MSc, Presenter
Hepatitis

Objectives

  • Evaluate interventions aimed at eliminating hepatitis C among key populations in the United States and other countries.
  • Discuss innovative care models and implementation strategies for managing HCV infection in priority populations.
  • Review treatment and retreatment strategies in hard-to-reach key populations of patients with HCV infection.
Chair

Ponni V. Perumalswami, MD, FAASLD

University of Michigan Medical Center
Chair

Tzu-Hao "Howard" Lee, MD

Baylor College of Medicine